WikiCitingRetracted

Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy

Revision as of 01:49, 7 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy; LM Xu, H Fang, WH Wang, J Jin, SL Wangae; 2013; doi_citing_unknown == Retraction == RETRACTED: Development and Validation of a New Outcome Score in Subglottic Stenosis; Gonfiotti, Alessandro; Jaus, Massimo Osvaldo; Barale, Daniel; Baiguera, Silvia; Polizzi, Leonardo; J; 2012-10-01 ; https://d...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Target ArticleEdit

Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy; LM Xu, H Fang, WH Wang, J Jin, SL Wangae; 2013; doi_citing_unknown

RetractionEdit

RETRACTED: Development and Validation of a New Outcome Score in Subglottic Stenosis; Gonfiotti, Alessandro; Jaus, Massimo Osvaldo; Barale, Daniel; Baiguera, Silvia; Polizzi, Leonardo; J; 2012-10-01

https://doi.org/10.1016/j.athoracsur.2012.05.107

Citation pieceEdit

Note: Open to append information.

Retrieved from "https://wikicitingretracted.org/index.php?title=Prognostic_significance_of_rituximab_and_radiotherapy_for_patients_with_primary_mediastinal_large_B-cell_lymphoma_receiving_doxorubicin-containing_chemotherapy&oldid=1696"